Intrinsic Value of S&P & Nasdaq Contact Us

uniQure N.V. QURE NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • NL • USD

SharesGrow Score
38/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$35.89
+108.1%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

uniQure N.V. (QURE) has a negative trailing P/E of -4.6, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 11.3 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -21.93%, forward earnings yield 8.82%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+108.1%).
  • Forward P/E 11.3 — analysts expect a return to profitability with estimated EPS of $1.52 for FY2030.
  • Trailing Earnings Yield -21.93% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 8.82% as earnings recover.
  • Analyst consensus target $35.89 (+108.1% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 38/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
38/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
MOAT
12/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — QURE

Valuation Multiples
P/E (TTM)-4.6
Forward P/E11.3
PEG RatioN/A
Forward PEGN/A
P/B Ratio4.56
P/S Ratio60.37
EV/EBITDA-10.0
Per Share Data
EPS (TTM)$-3.46
Forward EPS (Est.)$1.52
Book Value / Share$3.46
Revenue / Share$0.28
FCF / Share$-3.09
Yields & Fair Value
Earnings Yield-21.93%
Forward Earnings Yield8.82%
Dividend Yield0.00%
Analyst Target$35.89 (+108.1%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -1.9 0.11 2.20 5.59 -
2017 -6.6 -3.85 5.88 40.33 -
2018 -12.3 0.57 5.72 91.03 -
2019 -23.1 -0.63 8.87 393.68 -
2020 -12.9 1.05 6.59 42.83 -
2021 2.9 -0.01 1.60 1.82 -
2022 -8.4 0.06 2.23 9.95 -
2023 -1.0 -0.01 1.55 20.37 -
2024 -3.6 0.15 -127.24 31.68 -
2025 -6.9 0.23 6.92 85.48 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-2.93 $25.1M $-73.37M -292.3%
2017 $-2.98 $13.11M $-80.39M -613.3%
2018 $-2.34 $11.28M $-83.3M -738.2%
2019 $-3.20 $7.28M $-128.01M -1758.2%
2020 $-2.81 $37.51M $-125.02M -333.3%
2021 $7.04 $524M $329.59M 62.9%
2022 $-2.71 $106.48M $-126.79M -119.1%
2023 $-6.47 $15.84M $-308.48M -1947.1%
2024 $-4.92 $27.12M $-239.56M -883.4%
2025 $-3.46 $16.1M $-198.97M -1236%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-3.49 $-4.27 – $-3.16 $32.35M $20.88M – $42.99M 9
2027 $-2.95 $-3.44 – $-1.97 $108.05M $40.99M – $213.32M 7
2028 $-2.61 $-4.42 – $1.21 $178.18M $74.42M – $392.63M 7
2029 $-0.56 $-1.44 – $-0.14 $371.5M $155.17M – $818.64M 2
2030 $1.52 $0.37 – $3.90 $581.75M $242.99M – $1.28B 5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message